Prof Katja Weisel speaks to ecancer online at the EHA virtual conference 2020 about the CANDOR trial patient reported outcomes.
She explains how the patients reported their outcomes through a life-quality evaluation questionnaire, and explains why this feedback is so important.
Prof Weisel emphasises why this especially important in diseases like multiple myeloma because patients can live a long time with treatment, and constant feedback is important for a better quality of life.
ecancer's filming has been kindly supported by Amgen through the ecancer Global Foundation. ecancer is editorially independent and there is no influence over content.